MKS Inc. Common Stock
MKSI
$0.00
+7.49%
MKS Inc. is a technology company that provides foundational instruments, components, subsystems, and process control solutions for advanced semiconductor manufacturing, electronics packaging, and specialty industrial applications. It operates as a critical supplier within the semiconductor capital equipment ecosystem, enabling the miniaturization and complexity challenges of next-generation device manufacturing. The current investor narrative is heavily focused on the company's role in the semiconductor upcycle, with recent financial results showing strong revenue growth and margin expansion, positioning it as a key beneficiary of sustained capital investment in leading-edge chip fabrication.…
MKSI
MKS Inc. Common Stock
$0.00
Investment Opinion: Should I buy MKSI Today?
Rating & Thesis: Hold. MKSI presents a compelling but high-risk growth story where strong fundamental momentum is fully reflected, if not over-reflected, in a technically extended and volatile stock price. The lack of a clear analyst consensus underscores the uncertainty, making a cautious stance prudent.
Supporting Evidence: The valuation narrative is bifurcated: the trailing P/E of 36.5x appears rich, but the forward P/E of 19.6x and a PEG ratio of 0.65 suggest embedded growth expectations are substantial. Fundamentally, the company delivers with 10.6% YoY revenue growth, a 7.5% net margin, and robust $496M in TTM free cash flow. However, the stock's 188.7% one-year gain and position at 87% of its 52-week range signal that much of this positivity is already priced in, limiting near-term upside potential.
Risks & Conditions: The two biggest risks are valuation compression from its high trailing multiple and heightened volatility from its 1.896 beta. This Hold rating would upgrade to a Buy if the stock experiences a healthy pullback to the $210 support area (improving risk/reward) while maintaining its revenue growth trajectory above 10% and forward P/E below 20x. It would downgrade to a Sell if revenue growth decelerates below 5% YoY or gross margins contract below 38%. Relative to its own history and growth-adjusted peers, the stock is fairly valued to slightly overvalued on a trailing basis, but reasonably valued on forward estimates.
Sign up to view all
MKSI 12-Month Price Forecast
MKSI is a high-quality operator in a favorable cycle, but the investment case is a tale of two valuations: promising forward multiples are overshadowed by a technically exhausted chart. The neutral stance reflects the balance between solid fundamentals (40.5% gross margin, $496M FCF) and significant price/volatility risks. The stance would upgrade to bullish on a pullback to the $210-$220 range that improves the risk/reward profile, provided fundamentals remain intact. It would turn bearish if the next quarterly report shows revenue growth decelerating below 5% or a breakdown below the $200 psychological support level.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on MKS Inc. Common Stock's 12-month outlook, with a consensus price target around $0.00 and implied upside of — versus the current price.
Average Target
$0.00
5 analysts
Implied Upside
—
vs. current price
Analyst Count
5
covering this stock
Price Range
$0 - $0
Analyst target range
Analyst coverage for MKSI appears limited, with insufficient data provided on the exact number of covering analysts, consensus recommendation, or average price target. The provided data indicates only 5 analysts contributing to EPS estimates, which suggests this may be a mid-cap stock with less than full institutional coverage. Without a clear consensus target or distribution, it is difficult to quantify implied upside or downside; however, the wide range of recent institutional actions from 'Buy' to 'Sell' indicates high uncertainty and divergent views on the stock's prospects. The lack of comprehensive analyst targets typically implies higher volatility and less efficient price discovery, requiring investors to perform more independent fundamental and technical analysis.
Bulls vs Bears: MKSI Investment Factors
The evidence currently leans bullish, driven by strong fundamental performance including accelerating revenue, expanding margins, and robust cash flow. However, the bull case is critically tempered by extreme valuation and technical overextension following a massive rally. The single most important tension in the investment debate is whether the company's robust fundamental growth (10.6% YoY revenue, 45% sequential net income jump) can justify and sustain its premium valuation (36.5x trailing P/E) and elevated price level, or if the stock's high beta (1.896) and extended technical position will lead to a significant multiple compression during any market or sector weakness.
Bullish
- Explosive Revenue Growth & Momentum: Revenue grew 10.6% YoY in Q4 2025 to $1.033B, continuing a sequential quarterly climb from $936M in Q1. This acceleration, coupled with a 188.7% one-year stock price surge, demonstrates powerful operational and market momentum tied to the semiconductor upcycle.
- Strong Profitability & Margin Expansion: The company is solidly profitable with a trailing net margin of 7.5% and an operating margin of 14.37%. Gross margin of 40.46% indicates pricing power, and Q4 net income of $107M shows a significant 45% sequential increase from $74M in Q3, signaling improving earnings quality.
- Robust Free Cash Flow Generation: Trailing twelve-month free cash flow of $496 million provides substantial internal funding for growth initiatives and potential shareholder returns. This strong cash generation, alongside a healthy current ratio of 2.71, underpins financial stability despite leverage.
- Attractive Forward Valuation: The forward P/E of 19.6x represents a significant discount to the trailing P/E of 36.5x, reflecting high expected earnings growth. The PEG ratio of 0.65 suggests the stock may be undervalued relative to its growth prospects, assuming estimates are met.
Bearish
- Extreme Valuation & Technical Overextension: The stock trades at 87% of its 52-week high-to-low range after a 188.7% run-up, indicating it is extended and vulnerable to a pullback. The trailing P/E of 36.5x is at the upper end of its historical range, pricing in perfection and leaving little room for disappointment.
- High Volatility & Market Sensitivity: With a beta of 1.896, MKSI is approximately 90% more volatile than the broader market. This extreme sensitivity means the stock will amplify any market downturn, as evidenced by a maximum drawdown of -35.98% in the recent period.
- Leveraged Balance Sheet: A debt-to-equity ratio of 1.73 indicates a leveraged capital structure. While typical for the industry, this increases financial risk and interest expense sensitivity in a rising rate environment or during an industry downturn.
- Limited Analyst Coverage & High Uncertainty: Only 5 analysts contribute to EPS estimates, suggesting limited institutional coverage and potentially less efficient price discovery. The wide range of recent institutional actions from 'Buy' to 'Sell' points to high uncertainty and divergent views on the stock's future.
MKSI Technical Analysis
The stock is in a powerful, sustained uptrend, evidenced by a staggering 188.7% gain over the past year. As of the latest close of $234.66, the price is trading near the top of its 52-week range, approximately 87% of the distance from its 52-week low of $54.84 to its high of $269.91, indicating strong momentum but also suggesting the stock is extended and potentially vulnerable to a pullback. Recent momentum shows signs of consolidation after a sharp run-up; the stock is up 0.9% over the past month and 39.4% over three months, which, while positive, represents a significant deceleration from the 1-year pace, hinting at a potential pause or digestion phase. The stock exhibits high volatility, with a beta of 1.896, meaning it is approximately 90% more volatile than the broader market, which is critical for risk assessment. Key technical levels are the 52-week high of $269.91 as immediate resistance and the 52-week low of $54.84 as distant support; a decisive breakout above $270 would signal a resumption of the primary uptrend, while a break below recent consolidation lows near $210 could indicate a deeper correction is underway.
Beta
1.90
1.90x market volatility
Max Drawdown
-35.8%
Largest decline past year
52-Week Range
$56-$270
Price range past year
Annual Return
+335.5%
Cumulative gain past year
| Period | MKSI Return | S&P 500 |
|---|---|---|
| 1m | +17.2% | -0.3% |
| 3m | +43.0% | -2.0% |
| 6m | +111.1% | +3.5% |
| 1y | +335.5% | +36.2% |
| ytd | +52.1% | -0.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MKSI Fundamental Analysis
Revenue growth is robust and accelerating; Q4 2025 revenue reached $1.033 billion, representing a 10.6% year-over-year increase, and this follows a sequential quarterly growth trend from $936M in Q1 to $1.033B in Q4. The company is solidly profitable with net income of $107 million in the latest quarter and a gross margin of 40.46%, indicating strong pricing power and cost control within its niche. Profitability metrics are improving, as evidenced by a trailing net margin of 7.5% and an operating margin of 14.37%, with the latest quarterly net income of $107M showing a significant sequential increase from $74M in Q3. The balance sheet is healthy with a strong current ratio of 2.71 and substantial liquidity, while free cash flow generation is strong at $496 million on a trailing twelve-month basis, providing ample internal funding for growth and shareholder returns, though the debt-to-equity ratio of 1.73 indicates a leveraged capital structure typical for the industry.
Quarterly Revenue
$1.0B
2025-12
Revenue YoY Growth
+0.10%
YoY Comparison
Gross Margin
+0.40%
Latest Quarter
Free Cash Flow
$496000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MKSI Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE is 36.5x, while the forward PE is significantly lower at 19.6x, indicating the market expects substantial earnings growth in the coming year. Compared to sector averages, MKSI's trailing PE of 36.5x and Price-to-Sales ratio of 2.74x are at a premium to many hardware peers, which is likely justified by its superior growth profile and strategic positioning in the high-demand semiconductor equipment market. Historically, the stock's current trailing PE of 36.5x is near the upper end of its own historical range observed in recent quarters, which have fluctuated between approximately 20x and 95x, suggesting the market is pricing in optimistic future earnings expectations, leaving little room for disappointment.
PE
36.5x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -35x~210x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: MKSI's primary financial risk stems from its leveraged balance sheet, with a debt-to-equity ratio of 1.73, which could pressure cash flow if interest rates remain elevated. While revenue growth is robust at 10.6% YoY, the stock's valuation (36.5x trailing P/E) is critically dependent on this growth continuing unabated; any deceleration could trigger a severe multiple contraction. Furthermore, a gross margin of 40.46%, while healthy, saw a sequential decline from 46.7% in Q3, introducing a risk of margin pressure that could undermine profitability expectations.
Market & Competitive Risks: The stock faces significant valuation compression risk, as its trailing P/E of 36.5x and PS ratio of 2.74x trade at a premium to many hardware peers. Its extreme market sensitivity, with a beta of 1.896, means it is highly vulnerable to sector rotation out of growth or semiconductor-related stocks. As a supplier within the semiconductor capital equipment ecosystem, MKSI's fortunes are tied to the cyclicality of chip capex spending; any slowdown in leading-edge fabrication investment would directly impact demand for its foundational instruments and solutions.
Worst-Case Scenario: The worst-case scenario involves a combination of a semiconductor capex downturn coinciding with a broader market correction. This could trigger a vicious cycle of order push-outs, missed revenue estimates, margin contraction, and rapid multiple de-rating. Given the stock's high beta and extended technical position, a realistic downside could see it re-test its 52-week low of $54.84, representing a potential loss of approximately -77% from the current price of ~$235. A more probable severe bear case might align with a retracement to the recent significant support level near $210, implying a downside of about -11% from current levels, not accounting for further fundamental deterioration.
FAQ
The key risks are: 1) Valuation & Volatility Risk: The stock's high trailing P/E (36.5x) and extreme beta (1.896) make it prone to severe corrections in a market downturn. 2) Cyclical & Operational Risk: As a semiconductor supplier, its revenue is tied to cyclical capex spending; a slowdown would directly impact growth. Debt-to-equity of 1.73 also adds financial risk. 3) Execution Risk: The company must maintain its 40.5% gross margin and sequential revenue growth to justify its valuation. 4) Coverage Risk: Limited analyst coverage (5 on EPS) can lead to less efficient price discovery and higher volatility.
The 12-month forecast presents three scenarios. The Base Case (55% probability) sees the stock trading between $225 and $260 as growth meets expectations but valuation multiples compress from current highs. The Bull Case (25% probability) targets $269 to $300, requiring an acceleration of the semiconductor cycle and multiple expansion. The Bear Case (20% probability) warns of a drop to $180-$210 on a growth slowdown or market correction. The most likely outcome is the Base Case, which assumes the company executes well but the stock consolidates after its historic rally.
MKSI's valuation sends mixed signals. On a trailing basis, a P/E of 36.5x and Price/Sales of 2.74x suggest the stock is overvalued relative to many hardware peers, especially after its massive run-up. However, the forward P/E of 19.6x and a PEG ratio of 0.65 point to potential undervaluation if the company meets its high growth expectations. The market is currently paying a premium for anticipated future earnings growth. The verdict is that it is fairly valued to slightly overvalued on current results, but reasonably valued based on forward estimates, implying no margin of safety.
MKSI is a good buy only for investors with a high risk tolerance and a belief in the continuation of the semiconductor capital expenditure boom. The stock offers strong fundamentals, including 10.6% YoY revenue growth and robust free cash flow, but these are offset by extreme volatility (beta 1.9) and a price that has already rallied 188.7% in one year. The forward P/E of 19.6x offers a reasonable entry point for growth, but the lack of a clear analyst consensus adds uncertainty. It is not a good buy for conservative investors or those seeking stable income.
MKSI is more suitable for a medium- to long-term investment horizon of 2-3 years, allowing investors to ride the semiconductor cycle and for the company's earnings to grow into its valuation. Its high beta (1.896) and cyclical nature make it a poor choice for short-term trading unless one has a high conviction on near-term catalysts. The lack of a significant dividend (0.55% yield) also negates an income-oriented long-term hold. A minimum holding period of 12-18 months is suggested to navigate the inherent volatility and capture the underlying growth story.